Prefer to listen? Click on the audio player below.
Selective serotonin reuptake inhibitors, commonly known as SSRIs, are among the most widely prescribed medications for depression and anxiety. For some people, they can be profoundly helpful and even life-saving. For others, however, the experience is very different. Some individuals notice little improvement, while others develop worsening anxiety, irritability, insomnia, or emotional agitation after starting treatment.
This raises an important question: why do the same medications produce such different outcomes from one person to another?
According to Dr. J Dunn, the answer often lies in genetics and the body’s underlying biochemical pathways.
What SSRIs Actually Do
To understand why responses vary, it helps to first understand how SSRIs work.
Serotonin is a neurotransmitter involved in mood regulation, emotional stability, sleep, and many other neurological functions. After serotonin is released into the space between neurons, known as the synaptic cleft, it binds to receptors that allow nerve cells to communicate.
Normally, some of that serotonin is reabsorbed back into the neuron through a process called reuptake.
SSRIs work by blocking this reuptake process. By slowing the reabsorption of serotonin, the medication allows serotonin to remain active in the synaptic space for a longer period of time. This can increase serotonin signaling in the brain.
For some individuals, this can reduce depressive symptoms and improve emotional stability.
The Body Has to Make Serotonin First
One of the most overlooked aspects of serotonin-related depression is that the body must first be able to produce serotonin efficiently.
Serotonin is not created out of nothing. It begins with tryptophan, an amino acid obtained through dietary protein. Tryptophan is converted into 5-HTP and then into serotonin through a series of enzyme-driven steps.
These enzymes depend on nutrients and genetic efficiency to function properly.
If someone has genetic variants that slow these pathways, serotonin production may be impaired from the beginning. In these cases, the issue may not simply be serotonin reuptake, but serotonin synthesis itself.
Genetic Variants and Serotonin Production
Certain genetic variants can affect enzymes involved in serotonin production.
For example:
- Variants affecting tryptophan hydroxylase may slow the conversion of tryptophan into 5-HTP
- Variants affecting dopamine decarboxylase may reduce the conversion of 5-HTP into serotonin
These pathways also depend on important cofactors such as vitamin D.
If these systems are not functioning efficiently, serotonin levels may remain low regardless of whether reuptake is blocked.
This is one reason why some individuals may not respond strongly to SSRIs alone.
The Other Side of the Equation: Breaking Serotonin Down
Producing serotonin is only one part of the process. The body must also be able to regulate and break down serotonin appropriately.
If someone has genetic variants that slow serotonin breakdown, increasing serotonin activity further through an SSRI may create overstimulation rather than balance.
This can contribute to symptoms such as:
- Anxiety
- Irritability
- Agitation
- Restlessness
- Insomnia
- Emotional instability
In more severe situations, excessive serotonin activity can contribute to serotonin syndrome, a potentially dangerous condition involving overheating, sweating, confusion, and extreme agitation.
This helps explain why SSRIs can feel calming and stabilizing for some people while creating intense discomfort for others.
Depression Is More Complex Than “Low Serotonin”
The common idea that depression is simply caused by low serotonin is an oversimplification.
Mood regulation involves many interconnected systems, including:
- Dopamine pathways
- Stress hormone regulation
- Inflammation
- Nutrient status
- Sleep quality
- Genetic influences on neurotransmitter metabolism
In some cases, depression may involve serotonin deficiency. In others, the issue may involve dopamine imbalance, chronic stress activation, inflammation, or poor neurotransmitter breakdown.
This complexity is one reason why a medication that helps one person may not help another.
A More Personalized Approach
Dr. J emphasizes that understanding genetic pathways can provide a more individualized approach to mental health support.
Rather than assuming every person with depression needs the same intervention, this approach asks:
- Is the body producing serotonin efficiently?
- Are neurotransmitters being broken down properly?
- Are important nutrient cofactors missing?
- Is there overstimulation in other pathways?
In some cases, supporting the body’s natural ability to produce and regulate neurotransmitters may improve mood more effectively than simply blocking reuptake.
Natural Support Versus Medication
This discussion is not about rejecting medication.
For individuals in severe distress or crisis situations, antidepressants can be essential and life-saving. Mental health emergencies require professional support and careful medical supervision.
However, Dr. J argues that natural approaches aimed at supporting neurotransmitter production and biochemical balance should also be explored where appropriate.
This may include addressing:
- Nutrient deficiencies
- Vitamin D status
- Stress regulation
- Sleep quality
- Inflammation
- Neurotransmitter support pathways
The goal is to help the body function more naturally and efficiently, where possible.
Why Stopping SSRIs Abruptly Can Be Dangerous
One of the most important cautions discussed in this conversation is the danger of abruptly stopping antidepressants.
When someone takes SSRIs for an extended period of time, the brain adapts to those changes in serotonin signaling. Suddenly stopping the medication can create a sharp drop in serotonin activity before the brain has adjusted.
This can lead to severe emotional and physical symptoms.
Anyone considering reducing or discontinuing antidepressants should work closely with a qualified healthcare professional and never stop medication abruptly without guidance.
Understanding the Bigger Picture
Mental health is deeply connected to biology. Genetics, nutrition, stress, inflammation, sleep, and neurotransmitter pathways all influence how the brain functions.
Understanding these systems can help move the conversation beyond simplistic explanations and toward more personalized care.
Rather than asking only how to suppress symptoms, this approach asks why those symptoms are occurring in the first place.
The Takeaway
SSRIs can be highly effective for some individuals, but they are not universally beneficial for everyone. Genetics and biochemical individuality play a major role in how people respond to these medications.
Some individuals may struggle to produce serotonin efficiently, while others may struggle to regulate or break it down properly. These differences can dramatically influence whether SSRIs help, create side effects, or worsen symptoms.
A more personalized approach—one that considers genetics, nutrient status, neurotransmitter pathways, and overall biochemical balance—may provide deeper insight into why mental health symptoms occur and how to support the body more effectively.
Explore More from MyHappyGenes®
- Order a DNA Test Kit
- View a Sample Report - click “Sample Reports”
- Find a Practitioner
- Subscribe to the Newsletter
Important Information: This video is for educational purposes only and is not medical advice. Always consult your healthcare provider before making dietary or supplement changes.
